---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-074485"
form_type: "8-K"
ticker: "HEPA"
cik: "0001583771"
company_name: "Hepion Pharmaceuticals, Inc."
filed_at: "2022-06-27T23:59:59+00:00"
generated_at: "2026-06-24T22:54:50.015104+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Hepion Pharma annual meeting: equity plan & say-on-pay fail; 3 directors face majority withhold votes

## Summary
- Proposal 3 (2022 Omnibus Equity Incentive Plan) failed: 11.0M for, 20.1M against.
- Proposal 5 (say-on-pay) failed: 9.2M for, 21.6M against.
- Directors Gary Jacob, John Brancaccio, and Timothy Block each received more withhold votes than for votes.
- Proposal 4 (authorized share increase) adjourned to July 22, 2022 due to insufficient votes.
- Proposal 2 (ratify BDO USA as auditor) passed with 31.1M for.

## SEC filing metadata
- accession: 0001104659-22-074485
- form_type: 8-K
- ticker: HEPA
- cik: 0001583771
- company_name: Hepion Pharmaceuticals, Inc.
- filed_at: 2022-06-27T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1583771/000110465922074485/0001104659-22-074485-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1583771/000110465922074485/tm2219430d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-074485
- JSON: https://secwatch.observer/filing/0001104659-22-074485.json
- Plain text: https://secwatch.observer/filing/0001104659-22-074485.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.